Aarkstore - Anthrax - Pipeline Review, H1 2015

1
Aarkstore - Anthrax - Pipeline Review, H1 2015
www.aarkstore.com
2
Summary

• Global Markets Directs, Anthrax - Pipeline
  Review, H1 2015, provides an overview of
• the Anthraxs therapeutic pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Anthrax, complete with
  comparative analysis at various stages,
  therapeutics
• assessment by drug target, mechanism of action
  (MoA), route of administration (RoA) and
• molecule type, along with latest updates, and
  featured news and press releases. It also reviews
• key players involved in the therapeutic
  development for Anthrax and special features on
  late
• stage and discontinued projects.

www.aarkstore.com
3
Scope

• The report provides a snapshot of the global
  therapeutic landscape of Anthrax
• The report reviews key pipeline products under
  drug profile section which includes, product
• description, MoA and RD brief, licensing and
  collaboration details other developmental
• activities
• The report reviews key players involved in the
  therapeutics development for Anthrax and enlists
  all
• their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Anthrax products under
  development by companies and universities/research
  
• institutes based on information derived from
  company and industry-specific sources
• Pipeline products coverage based n various stages
  of development ranging from pre-registration till
• discovery and undisclosed stages

www.aarkstore.com
4
Reasons to buy

• Provides strategically significant competitor
  information, analysis, and insights to formulate
• effective RD development strategies
• Identify emerging players with potentially strong
  product portfolio and create effective counter
• strategies to gain competitive advantage
• Develop strategic initiatives by understanding
  the focus areas of leading companies
• Identify and understand important and diverse
  types of therapeutics under development for
• Anthrax
• Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline
• Devise corrective measures for pipeline projects
  by understanding Anthrax pipeline depth and
• focus of Indication therapeutics
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
• with the most attractive projects to enhance and
  expand business potential and Scope
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors
• that drove them from pipeline

www.aarkstore.com
5
Table of Contents

• Introduction 8
• Global Markets Direct Report Coverage 8
• Anthrax Overview 9
• Therapeutics Development 10
• Pipeline Products for Anthrax - Overview 10
• Pipeline Products for Anthrax - Comparative
  Analysis 11
• Anthrax - Therapeutics under Development by
  Companies 12
• Anthrax - Therapeutics under Investigation by
  Universities/Institutes 16
• Anthrax - Pipeline Products Glance 17
• Late Stage Products 17
• Clinical Stage Products 18
• Early Stage Products 19

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for Anthrax,
  H1 2015 13
• Number of Products under Development for Anthrax
  - Comparative Analysis, H1 2015 14
• Number of Products under Development by
  Companies, H1 2015 16
• Number of Products under Development by
  Companies, H1 2015 (Contd..1) 17
• Number of Products under Development by
  Companies, H1 2015 (Contd..2) 18
• Number of Products under Investigation by
  Universities/Institutes, H1 2015 19
• Comparative Analysis by Late Stage Development,
  H1 2015 20
• Comparative Analysis by Clinical Stage
  Development, H1 2015 21
• Comparative Analysis by Early Stage Development,
  H1 2015 22
• Products under Development by Companies, H1 2015
  23

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for Anthrax,
  H1 2015 13
• Number of Products under Development for Anthrax
  - Comparative Analysis, H1 2015 14
• Number of Products under Development by
  Companies, H1 2015 15
• Number of Products under Investigation by
  Universities/Institutes, H1 2015 19
• Comparative Analysis by Late Stage Development,
  H1 2015 20
• Comparative Analysis by Clinical Stage
  Development, H1 2015 21
• Comparative Analysis by Early Stage Products, H1
  2015 22
• Assessment by Monotherapy Products, H1 2015 60
• Number of Products by Top 10 Targets, H1 2015 62
• Number of Products by Stage and Top 10 Targets,
  H1 2015 62

www.aarkstore.com
8
Related Market Research reports

• Alpha- Antitrypsin Deficiency - Pipeline Review,
  H1 2015
•  
• Hyperphosphatemia - Pipeline Review, H1 2015
•  
• H3N2 Infection - Pipeline Review, H1 2015 
• Cough - Pipeline Review, H1 2015
•  
• Alopecia - Pipeline Review, H1 2015

www.aarkstore.com
9
Related Market Research reports

• Anthrax - Pipeline Review, H1 2015
• Degenerative Disc Disease - Pipeline Review, H1
  2015
• Male Infertility - Pipeline Review, H1 2015
•  
• Women Infertility - Pipeline Review, H1 2015
•  
• Nasopharyngeal Cancer - Pipeline Review, H1 2015

www.aarkstore.com
10
Aarkstore - Anthrax - Pipeline Review, H1 2015
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com